drugset / Trial / NCT01779492

A Randomized, Open-label, Multiple-dose, Two-sequence, Two-period Crossover Study to Investigate The Pharmacokinetics Between a GL2907 and Oxycontin CR Tab. 10mg in Healthy Male Volunteers

NCT01779492

Phase 1 Completed 24 enrolled GL Pharm Tech Corporation
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this clinical trial is to compare the pharmacokinetic characteristics of GL2907 XL 20mg tablet and Oxycontin CR 10mg tablet.

Timeline

Start
2013-04
Primary completion
2013-06
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxycodone Other / unclassified 10 mg
Subject Oxycodone Other / unclassified 20 mg

Indications

No indication recorded.